Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET)

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

John Ramage, Alia Ahmed, J. Ardill et al. · Gut · 2011 · 951 citations · Full text

Medicine, Endocrinology, Oncology +13

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE

Irene Virgolini, Valentina Ambrosini, Jamshed Bomanji et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 447 citations

Medicine, Nuclear Medicine, Radiology +16

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors

Sanjay Gupta, Marcella M. Johnson, Ravi Murthy et al. · Cancer · 2005 · 429 citations · Full text

Medicine, Oncology, Radiology +15

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

Francesco Panzuto, S. Nasoni, Massimo Falconi et al. · Endocrine Related Cancer · 2005 · 396 citations · Full text

Medicine, Oncology, Surgery +17